AA
Aman A Ohri
About Aman A Ohri
Data last updated:
Aman A Ohri has 3 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Ohvem Ocular Private Limited and Artham Lifesciences Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alpha 10 Medicament Private Limited at ₹5.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 May 2023 | 2023 | ₹5.15 Cr (FY 2025) | Active | |
| Director | 09 Oct 2025 | 2025 | – | Active | |
| Designated Partner | 13 Dec 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aman A Ohri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aman A Ohri
Aman A Ohri has 3 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Ohvem Ocular Private Limited and Artham Lifesciences Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alpha 10 Medicament Private Limited at ₹5.15 Cr (FY 2025).
Aman A Ohri is associated with 3 companies as Director and Designated Partner, including Alpha 10 Medicament Private Limited (₹5.15 Cr), Ohvem Ocular Private Limited, Artham Lifesciences Llp.
Aman A Ohri has expertise in General Business.
Aman A Ohri has 3 years in corporate governance.
By reported revenue, the largest current company of Aman A Ohri is Alpha 10 Medicament Private Limited, with revenue of ₹5.15 Cr (FY 2025).
Aman A Ohri currently holds positions at 3 companies: Alpha 10 Medicament Private Limited (₹5.15 Cr), Ohvem Ocular Private Limited, Artham Lifesciences Llp.